-
transdermal drug delivery. The candidate will work with industrial partners to conduct a specified programme of research aimed at advancing the preclinical development of immunosuppressive therapeutic drug
-
modalities to the diseased site in the small intestine. GENEGUT will tackle this delivery dilemma by utilising novel biomaterials to formulate RNA nanoparticles (NPs). The efficacy and mechanisms targeted by
Searches related to computational solid mechanics
Enter an email to receive alerts for computational-solid-mechanics positions